T
TriNetX
Health Tech & Medtech · Cambridge, United States · Founded 2013
Combines real-time access to longitudinal clinical data with state-of-the-art analytics MoreLess
TriNetX operates as a global health research network that optimizes clinical research and enables discoveries through the generation of real world evidence (RWE). The company serves healthcare organizations, pharmaceutical companies, and researchers by providing real-time access to clinical data from the largest global network of healthcare organizations. TriNetX operates in the healthcare and life sciences market, focusing on improving the efficiency and effectiveness of clinical trials and observational research studies.
The business model revolves around offering a data-driven approach to clinical trial design and feasibility processes, allowing clients to quickly gain insights into patient treatments and outcomes. TriNetX makes money through subscriptions to its data and analytics platform, as well as through partnerships and collaborations with healthcare organizations and pharmaceutical companies.
TriNetX is committed to community involvement and the democratization of software tools, as evidenced by their open source contributions like the OPS to SNOMED CT Mapping solution. The platform supports region-specific studies compliant with local privacy regulations in over 25 countries, making it a versatile tool for global research.
Keywords: clinical research, real world evidence, healthcare data, pharmaceutical, observational studies, data analytics, global network, clinical trials, open source, patient outcomes.
Company overview
TriNetX company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2013
- Headquarters
- Cambridge, United States
- Employees
- 277
- Open positions
- 11
- Dealroom signal
- 66.1
- Investment activity
- 1 companies · latest Jan 2022
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
TriNetX funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| BUYOUTOther financing | Sep 2020 | $0 | — | The Carlyle Group | — |
| SERIES DOther financing | Mar 2019 | $40M | $160M | Itochu Technology Ventures · Mitsui Global Investment · F2 Ventures · MPM BioImpact | ↗ |
| CONVERTIBLEOther financing | Feb 2016 | $2.5M | — | Undisclosed | — |
| SERIES BOther financing | Jun 2015 | $13M | $52M | MPM BioImpact · Deerfield · F2 Ventures | — |
| SPINOUTOther financing | Jan 2000 | $0 | — | Ghent University | — |
Growth signals
TriNetX website traffic
Latest recorded traffic for TriNetX is 200K monthly website visits, up 42.9% over the last three months. TriNetX's team declined 4.2% over the past year.
Hiring
Open positions at TriNetX
Current openings linked to this company in Dealroom.
Comparisons
TriNetX compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 CerenionMedical device company providing AI-based software for monitoring of brain function in intensive care |
Oulu, Finland | Operational | 20 | $11M | $19M |
 NBT AnalyticsEEG analysis for clinical trials |
Amsterdam, Netherlands | Operational | |||
 IcometrixAI-powered software for quantitative brain scan analysis |
Leuven, Belgium | Acquired | |||
 PepticomAn Artificial Intelligence (AI) company for the discovery of novel molecules in the Pharmaceutical and Agricultural markets |
Jerusalem, Israel | Operational | |||
 Blackford AnalysisAlgorithmic solutions to problems requiring real-time analysis of datasets |
Edinburgh, United Kingdom | Acquired | |||
 Pieces TechSoftware which interprets patient data in real time |
Irving, United States | Acquired | |||
 Aiforia TechnologiesAI-powered pathology image analysis software for researchers |
Helsinki, Finland | Operational | |||
 CongenicaClinical genomics analytics platform |
Hinxton, United Kingdom | Acquired |
Capital deployed
TriNetX investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
TriNetX's talent
Source: Dealroom Talent Intelligence.
Investors
8 investors on TriNetX's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where TriNetX has talent and traffic
team presence
In the news
Latest news about TriNetX
Recent press, funding announcements, and product moves mentioning TriNetX — open to read from the original sources.
Market sentiment
What the market is saying about TriNetX
An AI-synthesized read of the highest-engagement posts about TriNetX on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See TriNetX’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.